University Of Michigan Rogel Cancer Center
Clinical trials sponsored by University Of Michigan Rogel Cancer Center, explained in plain language.
-
MRI-Guided radiation boosts hope for tough head and neck cancers
Disease control CompletedThis study tested a new way to give radiation therapy to people with advanced head and neck cancer. Doctors used a special MRI scan to find the toughest parts of the tumor and gave those areas a higher dose of radiation, while keeping standard doses to healthy tissues. The goal w…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New combo shows promise for tough bile duct cancer
Disease control CompletedThis study tested a mix of immunotherapy (nivolumab) and chemotherapy drugs in 34 people with advanced bile duct cancer that had gotten worse after initial treatment. The goal was to see if the combination could shrink tumors or slow the cancer's growth. The approach aims to cont…
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo therapy shows promise for Tough-to-Treat lymphoma
Disease control CompletedThis study tested a combination of two drugs, nivolumab and cabiralizumab, in 4 adults with a rare and aggressive blood cancer called peripheral T-cell lymphoma that had come back or stopped responding to treatment. The goal was to see if the drug pair could shrink tumors. The tr…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Could a cheap diabetes pill slow down CLL progression?
Disease control CompletedThis study tested whether metformin, a common and inexpensive diabetes medication, could help control chronic lymphocytic leukemia (CLL) in 37 patients whose disease had returned after prior treatment or who had a specific genetic change (11q deletion). Researchers monitored how …
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Radiation boost may stall resistant prostate cancer
Disease control CompletedThis study looked at men with a type of prostate cancer that no longer responds to hormone therapy and has spread to only a few spots in the body. Researchers wanted to see if adding focused radiation to standard treatments could delay the cancer from growing or spreading further…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Potato power: simple supplement may tame transplant danger
Disease control CompletedThis study tested whether a dietary supplement made from potato starch could lower the risk of graft-versus-host disease (GVHD) in people receiving a stem cell transplant. GVHD happens when donor cells attack the patient's body. The supplement was given to 107 participants before…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Immunotherapy boosts standard treatment for aggressive throat cancer
Disease control CompletedThis study tested whether adding the immunotherapy drug nivolumab to standard radiation and chemotherapy can help people with high-risk HPV-related throat cancer live longer without their cancer growing. Twenty-six participants received the combination treatment. The goal was to …
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Could a $10 combo stop colon cancer before it starts?
Prevention CompletedThis study looked at whether taking omeprazole (a heartburn drug) and low-dose aspirin daily for about a month can help prevent colon polyps in people at high risk. Twenty-one adults with a history of multiple polyps took both pills before their first meal each day. Researchers t…
Phase: EARLY_PHASE1 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Prevention
Last updated May 11, 2026 20:41 UTC
-
Finger pressure vs. joint pain: new hope for breast cancer survivors
Symptom relief CompletedThis study looked at whether self-acupressure (like acupuncture but without needles) can help reduce joint pain and stiffness caused by aromatase inhibitor therapy in postmenopausal women with breast cancer. Fifty participants learned to apply pressure to specific points on their…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated May 16, 2026 23:50 UTC
-
Fish oil may help breast cancer patients stick with treatment
Symptom relief CompletedThis study tested whether omega-3 fatty acid supplements can reduce joint pain and stiffness caused by aromatase inhibitor therapy in postmenopausal women with hormone receptor positive breast cancer. 77 participants took omega-3 supplements soon after starting their cancer medic…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated May 16, 2026 23:49 UTC
-
Pressing away fatigue: acupressure trial for young cancer survivors shows promise
Symptom relief CompletedThis study tested whether young cancer survivors (ages 15-39) can learn to do acupressure on themselves to reduce fatigue. 42 participants who had finished cancer treatment at least 3 months ago and still felt tired were taught relaxing acupressure. The goal was to see if it's pr…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
Acupressure offers hope for tired ovarian cancer survivors
Symptom relief CompletedThis study looked at whether acupressure, a technique where you apply gentle pressure to specific spots on the body, can help reduce severe tiredness in women who have had ovarian cancer. 171 survivors took part, and researchers measured their fatigue and quality of life over 24 …
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC
-
Writing away worries: new study helps young cancer survivors cope with body image
Symptom relief CompletedThis study tested whether a simple at-home writing program could help teens and young adults (ages 15-39) who finished cancer treatment feel less distressed about their body image and less anxious. Thirty survivors wrote about their body image for four weeks. The goal was to see …
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated May 14, 2026 12:01 UTC
-
Can a smartphone app ease the burden of stem cell transplant caregiving?
Symptom relief CompletedThis study looked at whether a mobile phone app called Roadmap 2.0 could improve the quality of life for caregivers and patients going through a stem cell transplant. 372 caregivers and patients took part. The app was designed to provide support and track health, with the goal of…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated May 11, 2026 20:53 UTC
-
Nerve surgery offers hope for breast cancer survivors in pain
Symptom relief CompletedThis study tested a surgical procedure called RPNI to treat chronic pain that can occur after mastectomy. 26 participants who had pain for at least six months after surgery were followed for about a year. The goal was to see if the surgery reduces pain, improves mood, and lowers …
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC
-
Michigan study tests new ways to boost genetic testing in cancer patients
Knowledge-focused CompletedThis study looked at whether a special website or coaching phone calls could help more people with a personal or family history of certain cancers get genetic testing. Over 800 participants were randomly assigned to use a mobile website, receive two motivational coaching calls, o…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Knowledge-focused
Last updated May 16, 2026 23:49 UTC
-
New web tool aims to keep low-risk prostate cancer patients on track
Knowledge-focused CompletedThis pilot study tested a web-based tool called MAP to help men with low-risk prostate cancer stay on active surveillance. Active surveillance means closely monitoring the cancer instead of treating it right away. The study enrolled 39 men aged 55 and older and measured how well …
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
New tool aims to curb overtreatment of Low-Risk thyroid cancer
Knowledge-focused CompletedThis pilot study tested a tool called CQUPLE to help 50 patients newly diagnosed with low-risk thyroid cancer make informed treatment choices. Participants were randomly assigned to receive the tool or usual care before their surgeon visit. The study measured how acceptable and f…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Family genetic testing study aims to prevent cancer in relatives
Knowledge-focused CompletedThis study looked at ways to help cancer patients encourage their relatives to get genetic testing for inherited cancer risk. Over 3,000 patients and their family members took part. The goal was to see if a virtual platform could make it easier for relatives to get tested and tal…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC